[go: up one dir, main page]

BR0210869A - Compound, pharmaceutical composition, process of preparing a pharmaceutical composition, methods of treating an individual suffering from a disorder, depression and anxiety, obesity, overactive bladder and a disorder in an individual, reducing an individual's body mass and relieve urinary urge incontinence and the symptoms of a disorder in an individual - Google Patents

Compound, pharmaceutical composition, process of preparing a pharmaceutical composition, methods of treating an individual suffering from a disorder, depression and anxiety, obesity, overactive bladder and a disorder in an individual, reducing an individual's body mass and relieve urinary urge incontinence and the symptoms of a disorder in an individual

Info

Publication number
BR0210869A
BR0210869A BR0210869-0A BR0210869A BR0210869A BR 0210869 A BR0210869 A BR 0210869A BR 0210869 A BR0210869 A BR 0210869A BR 0210869 A BR0210869 A BR 0210869A
Authority
BR
Brazil
Prior art keywords
individual
disorder
pharmaceutical composition
compound
preparing
Prior art date
Application number
BR0210869-0A
Other languages
Portuguese (pt)
Inventor
Mohammad R Marzabadi
John Wetzel
John E Deleon
Yu Jiang
Chien-An Chen
Kai Lu
Bharat Lagu
Original Assignee
Synaptic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptic Pharma Corp filed Critical Synaptic Pharma Corp
Priority claimed from PCT/US2002/021063 external-priority patent/WO2003004027A1/en
Publication of BR0210869A publication Critical patent/BR0210869A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, PROCESSO DE PREPARAR UMA COMPOSIçãO FARMACêUTICA, MéTODOS DE TRATAR UM INDIVìDUO QUE SOFRE DE UM DISTúRBIO, DE DEPRESSãO E DE ANSIEDADE, OBESIDADE, BEXIGA HIPERATIVA E UM DISTúRBIO EM UM INDIVìDUO, DE REDUZIR A MASSA CORPORAL DE UM INDIVìDUO E DE ALIVIAR INCONTINêNCIA DE URGêNCIA URINáRIA E OS SINTOMAS DE UM DISTúRBIO EM UM INDIVìDUO". A invenção refere-se a compostos que são antagonistas seletivos para receptores de hormónio concentrador de melanina (MCH1). A invenção proporciona uma composição farmacêutica compreendendo uma quantidade terapeuticamente efetiva do composto da invenção e um veículo farmaceuticamente aceitável. Esta invenção proporciona uma composição farmacêutica preparada combinando-se uma quantidade terapeuticamente efetiva do composto desta invenção e um veículo farmaceuticamente aceitável. Esta invenção proporciona adicionalmente um processo para preparar uma composição farmacêutica compreendendo combinar uma quantidade terapeuticamente efetiva do composto da invenção e um veículo farmaceuticamente aceitável."COMPOUND, PHARMACEUTICAL COMPOSITION, PROCESS OF PREPARING A PHARMACEUTICAL COMPOSITION, METHODS OF TREATING AN INDIVIDUAL SUFFERING FROM A DISORDER, DEPRESSION AND ANXIETY, OBESITY, HYDERATIVE BLADDER AND AN INDIVIDUAL DISTURAL BODY TO RELIEVE URINARY URGENCY INCONTINENCE AND THE SYMPTOMS OF A DISTURBANCE IN AN INDIVIDUAL ". The invention relates to compounds which are selective antagonists for melanin concentrating hormone (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition prepared by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for preparing a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

BR0210869-0A 2001-07-05 2002-07-03 Compound, pharmaceutical composition, process of preparing a pharmaceutical composition, methods of treating an individual suffering from a disorder, depression and anxiety, obesity, overactive bladder and a disorder in an individual, reducing an individual's body mass and relieve urinary urge incontinence and the symptoms of a disorder in an individual BR0210869A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89979401A 2001-07-05 2001-07-05
US4258201A 2001-07-09 2001-07-09
PCT/US2002/021063 WO2003004027A1 (en) 2001-07-05 2002-07-03 Substituted anilinic piperidines as mch selective antagonists

Publications (1)

Publication Number Publication Date
BR0210869A true BR0210869A (en) 2004-06-29

Family

ID=32599475

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210869-0A BR0210869A (en) 2001-07-05 2002-07-03 Compound, pharmaceutical composition, process of preparing a pharmaceutical composition, methods of treating an individual suffering from a disorder, depression and anxiety, obesity, overactive bladder and a disorder in an individual, reducing an individual's body mass and relieve urinary urge incontinence and the symptoms of a disorder in an individual

Country Status (1)

Country Link
BR (1) BR0210869A (en)

Similar Documents

Publication Publication Date Title
BR0312256A (en) Compound, pharmaceutical composition, process for the preparation of a pharmaceutical composition, and method of treating an individual suffering from an mch1 receptor mediated disorder and treating an individual suffering from depression, anxiety, urge incontinence or obesity
BRPI0406725A (en) Compound, pharmaceutical composition, process for preparing it, and methods for treating an individual suffering from an affective disorder, treating an individual suffering from an urinary disorder, and treating an individual suffering from an eating disorder
BR0010138A (en) Glucocorticoid receptor modulators
MXPA02001306A (en) Pharmaceutical compositions for the treatment of cns and other discorders.
WO2002060392A3 (en) Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
WO2002053177A3 (en) Agents and methods for treating pain
UA49796C2 (en) paroxetine hydrochloride anhydrate, method for preparing the above, paroxetine hydrochloride, method of preparing the above, method of treating and/or diseases preventing and pharmaceutical composition
ATE456953T1 (en) TREATMENT OF AMYOTROPHIC LATERAL SCLERosis WITH PYRIMETHAMINE AND ANALOGS
CA2440605A1 (en) Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
BR0200246A (en) Combination treatment for depression
BR0312257A (en) Compound, pharmaceutical composition, process for the preparation thereof, and method of treating an individual suffering from an mch1 receptor mediated disorder, and an individual suffering from depression, anxiety, urinary incontinence, or obesity
EP1213031A3 (en) Combination treatment for depression, anxiety and psychosis comprising an antidepressant and/or anxiolytic and a D4 receptor antagonist
TW200631956A (en) Azabenzoxazoles for the treatment of CNS disorders
BR0104345A (en) Combined treatment for depression and anxiety
BR0210869A (en) Compound, pharmaceutical composition, process of preparing a pharmaceutical composition, methods of treating an individual suffering from a disorder, depression and anxiety, obesity, overactive bladder and a disorder in an individual, reducing an individual's body mass and relieve urinary urge incontinence and the symptoms of a disorder in an individual
MXPA05013104A (en) Method for the treatment or prevention of lower urinary tract symptoms.
HUP0203050A2 (en) Treating endometriosis or infertility, or improving fertility
BR9814867A (en) Method for treating disease-related or drug-induced dyskinesias
UA85575C2 (en) 4-aryl piperidines
WO2003043640A3 (en) Treatment of major depressive disorder using glucocorticoid receptor antagonists
CA2671776A1 (en) Gal3 receptor antagonists for the treatment of depression
WO2000004012A8 (en) COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
EP1159970A3 (en) A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss, comprising a nicotine receptor partial agonist and an anti-obesity agent
ATE545627T1 (en) SMOOTH MUSCLE SPASMOLYTICS
WO2004034967A3 (en) 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: H. LUNDBECK A/S (DK)

Free format text: TRANSFERIDO DE: SYNAPTIC PHARMACEUTICAL CORPORATION

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.